Close Menu

NEW YORK (GenomeWeb) – Akonni Biosystems announced today it has received FDA 510(k) clearance for its TruDiagnosis molecular diagnostics system and a pharmacogenomics assay to identify genetic signatures associated with metabolism of the blood thinner warfarin (Coumadin). 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.